Skip to main content
SpringerLink
Log in
Book cover

Cancer Pain pp 191–201Cite as

Noncancer-Related Pain in Daily Practice

  • Chapter
  • First Online:

Abstract

Noncancer-related pain could be experienced by many cancer patients. Many treatments as well as degenerative disorders only distantly related to cancer (e.g. cachexia) may result in persistent, difficult-to-treat pain. Prevalence of this type of pain can be growing as cancer patients tend to live longer with their disease and many of them can be cured, sometimes at the cost of persistent noncancer-related pain. In this chapter, I shall discuss in more details pain that originates from nerve compression due to the atrophy of supporting tissues. This atrophy can be spontaneous as in cachexia, or it may be induced by the frequent and chronic use of corticosteroids, mainly dexamethasone. Another pain problem frequently encountered by patients suffering or cured from cancer is osteoporosis induced by either steroids or opioids. Skin can also get atrophic and is prone to damages, which can be painful and may heal poorly. Specific treatment of noncancer-related pain might help in keeping the opioid and other analgesics doses as low as possible and contribute to better overall pain control and better mobility of the patients.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Quintner JL, Bove GM. From neuralgia to peripheral neuropathic pain: evolution of a concept. Reg Anesth Pain Med. 2001;26:368–72.

    PubMed  CAS  Google Scholar 

  2. Koltzenburg M, Wall PD, McMahon SB. Does the right side know what the left is doing? Trends Neurosci. 1999;22:122–7.

    Article  PubMed  CAS  Google Scholar 

  3. Maigne JY, Maigne R, Guerin-Surville H. Anatomic study of the lateral cutaneous rami of the subcostal and iliohypogastric nerves. Surg Radiol Anat. 1986;8:251–6.

    Article  PubMed  CAS  Google Scholar 

  4. Prasad S, Galetta S. Trigeminal neuralgia: historical notes and current concepts. Neurologist. 2009;15:87–94.

    Article  PubMed  Google Scholar 

  5. Schestatsky P, Llado-Carbo E, Casanova-Molla J, Alvarez-Blanco S, Valls-Sole J. Small fibre function in patients with meralgia paresthetica. Pain. 2008;139:342–8.

    Article  PubMed  Google Scholar 

  6. Daemen MA, Kurvers HA, Kitslaar PJ, Slaaf DW, Bullens PH, Van den Wildenberg FA. Neurogenic inflammation in an animal model of neuropathic pain. Neurol Res. 1998;20:41–5.

    PubMed  CAS  Google Scholar 

  7. Mosconi T, Kruger L. Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: ultrastructural morphometric analysis of axonal alterations. Pain. 1996;64:37–57.

    Article  PubMed  CAS  Google Scholar 

  8. Polomano RC, Mannes AJ, Clark US, Bennett GJ. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain. 2001;94:293–304.

    Article  PubMed  CAS  Google Scholar 

  9. Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain. 1999;80:453–62.

    Article  PubMed  CAS  Google Scholar 

  10. Vorster W, Lange CP, Briet RJ, et al. The sensory branch distribution of the suprascapular nerve: an anatomic study. J Shoulder Elbow Surg. 2008;17:500–2.

    Article  PubMed  Google Scholar 

  11. Johansson A, Bennett GJ. Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth. 1997;22:59–65.

    Article  PubMed  CAS  Google Scholar 

  12. Zylicz Z. Entrapment neuropathies. Adv Pall Med. 2010;9:103–8.

    Google Scholar 

  13. McCully SP, Suprak DN, Kosek P, Karduna AR. Suprascapular nerve block results in a compensatory increase in deltoid muscle activity. J Biomech. 2007;40:1839–46.

    Article  PubMed  Google Scholar 

  14. Feigl GC, Anderhuber F, Dorn C, Pipam W, Rosmarin W, Likar R. Modified lateral block of the suprascapular nerve: a safe approach and how much to inject? A morphological study. Reg Anesth Pain Med. 2007;32:488–94.

    PubMed  Google Scholar 

  15. Penn J, Zylicz Z. Could shoulder pain be suprascapular nerve entrapment? Eur J Pall Care. 2006;13:98–100.

    Google Scholar 

  16. Taskaynatan MA, Yilmaz B, Ozgul A, Yazicioglu K, Kalyon TA. Suprascapular nerve block versus steroid injection for non-specific shoulder pain. Tohoku J Exp Med. 2005;205:19–25.

    Article  PubMed  Google Scholar 

  17. Fewtrell MS, Sapsford DJ, Herrick MJ, Noble-Jamieson G, Russell RI. Continuous axillary nerve block for chronic pain. Arch Dis Child. 1994;70:54–5.

    Article  PubMed  CAS  Google Scholar 

  18. Shibata Y, Nishiwaki K. Ultrasound-guided intercostal approach to thoracic paravertebral block. Anesth Analg. 2009;109:996–7.

    Article  PubMed  Google Scholar 

  19. Ben-Ari A, Moreno M, Chelly JE, Bigeleisen PE. Ultrasound-guided paravertebral block using an intercostal approach. Anesth Analg. 2009;109:1691–4.

    Article  PubMed  Google Scholar 

  20. Seror P, Seror R. Meralgia paresthetica: clinical and electrophysiological diagnosis in 120 cases. Muscle Nerve. 2006;33:650–4.

    Article  PubMed  CAS  Google Scholar 

  21. Haim A, Pritsch T, Ben-Galim P, Dekel S. Meralgia paresthetica: a retrospective analysis of 79 patients evaluated and treated according to a standard algorithm. Acta Orthop. 2006;77:482–6.

    Article  PubMed  Google Scholar 

  22. Grossman MG, Ducey SA, Nadler SS, Levy AS. Meralgia paresthetica: diagnosis and treatment. J Am Acad Orthop Surg. 2001;9:336–44.

    PubMed  CAS  Google Scholar 

  23. Tumber PS, Bhatia A, Chan VW. Ultrasound-guided lateral femoral cutaneous nerve block for meralgia paresthetica. Anesth Analg. 2008;106:1021–2.

    Article  PubMed  Google Scholar 

  24. Moucharafieh R, Wehbe J, Maalouf G. Meralgia paresthetica: a result of tight new trendy low cut trousers (‘taille basse’). Int J Surg. 2008;6:164–8.

    Article  PubMed  Google Scholar 

  25. Mayne A, Delire V, Collard E, Randour P, Joucken K, Buche M. Possible treatment for meralgia paresthetica after coronary bypass operations. J Thorac Cardiovasc Surg. 1992;104:1489–90.

    PubMed  CAS  Google Scholar 

  26. Waldman SD. Obturator neuralgia. In: Atlas of uncommon pain syndromes. Philadelphia: Saunders-Elsevier; 2008.

    Google Scholar 

  27. Vasilev SA. Obturator nerve injury: a review of management options. Gynecol Oncol. 1994;53:152–5.

    Article  PubMed  CAS  Google Scholar 

  28. Fujiwara Y, Sato Y, Kitayama M, Shibata Y, Komatsu T, Hirota K. Obturator nerve block using ultrasound guidance. Anesth Analg. 2007;105:888–9.

    Article  PubMed  Google Scholar 

  29. Rogers LR, Borkowski GP, Albers JW, Levin KH, Barohn RJ, Mitsumoto H. Obturator mononeuropathy caused by pelvic cancer: six cases. Neurology. 1993;43:1489–92.

    Article  PubMed  CAS  Google Scholar 

  30. Lewis M, Hay EM, Paterson SM, Croft P. Local steroid injections for tennis elbow: does the pain get worse before it gets better? Results from a randomized controlled trial. Clin J Pain. 2005;21:330–4.

    Article  PubMed  Google Scholar 

  31. Donohoe CL, Ryan AM, Reynolds JV. Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract. 2011;2011:601434.

    PubMed  Google Scholar 

  32. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.

    Article  PubMed  Google Scholar 

  33. Cummings M, Baldry P. Regional myofascial pain: diagnosis and management. Best Pract Res Clin Rheumatol. 2007;21:367–87.

    Article  PubMed  Google Scholar 

  34. Twycross RG, Fairfield S. Pain in far-advanced cancer. Pain. 1982;14:303–10.

    Article  PubMed  CAS  Google Scholar 

  35. Twycross R, Harcourt J, Bergl S. A survey of pain in patients with advanced cancer. J Pain Symptom Manage. 1996;12:273–82.

    Article  PubMed  CAS  Google Scholar 

  36. Torres Lacomba M, Mayoral del Moral O, Coperias Zazo JL, Gerwin RD, Goni AZ. Incidence of myofascial pain syndrome in breast cancer surgery: a prospective study. Clin J Pain. 2010;26:320–5.

    Article  PubMed  Google Scholar 

  37. Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118:92–6.

    Article  PubMed  CAS  Google Scholar 

  38. Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes–prolonged effects from a single injection. Pain. 2006;122:126–9.

    Article  PubMed  CAS  Google Scholar 

  39. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004;328:991.

    Article  PubMed  CAS  Google Scholar 

  40. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev. 2003;55:1–20.

    Article  PubMed  CAS  Google Scholar 

  41. Iadarola MJ, Mannes AJ. The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr Top Med Chem. 2011;11:2171–9.

    Article  PubMed  CAS  Google Scholar 

  42. Vanscheidt W, Sadjadi Z, Lillieborg S. EMLA anaesthetic cream for sharp leg ulcer debridement: a review of the clinical evidence for analgesic efficacy and tolerability. Eur J Dermatol. 2001;11:90–6.

    PubMed  CAS  Google Scholar 

  43. Weise KL, Nahata MC. EMLA for painful procedures in infants. J Pediatr Health Care. 2005;19:42–7; quiz 8–9.

    PubMed  Google Scholar 

  44. Lander JA, Weltman BJ, So SS. EMLA and amethocaine for reduction of children’s pain associated with needle insertion. Cochrane Database Syst Rev. 2006; (3):CD004236.

    Google Scholar 

  45. Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J. 5 % lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review. Acta Neurol Scand. 2011;123:295–309.

    Article  PubMed  CAS  Google Scholar 

  46. Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5 % lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin. 2010;26:1607–19.

    Article  PubMed  CAS  Google Scholar 

  47. Garnock-Jones KP, Keating GM. Lidocaine 5 % medicated plaster: a review of its use in postherpetic neuralgia. Drugs. 2009;69:2149–65.

    Article  PubMed  CAS  Google Scholar 

  48. Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J. 5 % Lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review. Swiss Med Wkly. 2010;140:297–306.

    PubMed  CAS  Google Scholar 

  49. Liedgens H, Hertel N, Gabriel A, et al. Cost-effectiveness analysis of a lidocaine 5 % medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a German perspective. Clin Drug Investig. 2008;28:583–601.

    Article  PubMed  CAS  Google Scholar 

  50. Dakin H, Nuijten M, Liedgens H, Nautrup BP. Cost-effectiveness of a lidocaine 5 % medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom. Clin Ther. 2007;29:1491–507.

    Article  PubMed  CAS  Google Scholar 

  51. Rovensky J, Micekova D, Gubzova Z, et al. Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5 % ibuprofen cream. Drugs Exp Clin Res. 2001;27:209–21.

    PubMed  CAS  Google Scholar 

  52. Moore RA. Topical nonsteroidal antiinflammatory drugs are effective in osteoarthritis of the knee. J Rheumatol. 2004;31:1893–5.

    PubMed  Google Scholar 

  53. Biswal S, Medhi B, Pandhi P. Longterm efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: metaanalysis of randomized placebo controlled clinical trials. J Rheumatol. 2006;33:1841–4.

    PubMed  CAS  Google Scholar 

  54. Kose-Ozkan C, Savaser A, Tas C, Ozkan Y. The development and in vitro evaluation of sustained release tablet formulations of benzydamine hydrochloride and its determination. Comb Chem High Throughput Screen. 2010;13:683–9.

    Article  PubMed  CAS  Google Scholar 

  55. Cingi C, Songu M, Ural A, Yildirim M, Erdogmus N, Bal C. Effects of chlorhexidine/benzydamine mouth spray on pain and quality of life in acute viral pharyngitis: a prospective, randomized, double-blind, placebo-controlled, multicenter study. Ear Nose Throat J. 2010;89:546–9.

    PubMed  Google Scholar 

  56. Carlucci G, Iuliani P, Di Federico L. Simultaneous determination of benzydamine hydrochloride and five impurities in an oral collutory as a pharmaceutical formulation by high-performance liquid chromatography. J Chromatogr Sci. 2010;48:854–9.

    Article  PubMed  CAS  Google Scholar 

  57. Karavana Hizarcioglu SY, Sezer B, Guneri P, et al. Efficacy of topical benzydamine hydrochloride gel on oral mucosal ulcers: an in vivo animal study. Int J Oral Maxillofac Surg. 2011;40:973–8.

    Article  PubMed  CAS  Google Scholar 

  58. Stein C, Schafer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med. 2003;9:1003–8.

    Article  PubMed  CAS  Google Scholar 

  59. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995;332:1685–90.

    Article  PubMed  CAS  Google Scholar 

  60. Krajnik M, Zylicz Z. Topical morphine for cutaneous cancer pain. Palliat Med. 1997;11:325.

    Article  PubMed  CAS  Google Scholar 

  61. Krajnik M, Zylicz Z, Finlay I, Luczak J, van Sorge AA. Potential uses of topical opioids in palliative care–report of 6 cases. Pain. 1999;80:121–5.

    Article  PubMed  CAS  Google Scholar 

  62. Stein C, Pfluger M, Yassouridis A, et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest. 1996;98:793–9.

    Article  PubMed  CAS  Google Scholar 

  63. Jansen MPM, van der Horst JC, van der Valk PGM, Zylicz Z, van Sorge AA. Lack of analgesic effect from topical morphine in painful arterial leg ulcers. IASP Congress of Pain, Sydney; 2005; 1789:292.

    Google Scholar 

  64. Peyman GA, Rahimy MH, Fernandes ML. Effects of morphine on corneal sensitivity and epithelial wound healing: implications for topical ophthalmic analgesia. Br J Ophthalmol. 1994;78:138–41.

    Article  PubMed  CAS  Google Scholar 

  65. Stiles J, Honda CN, Krohne SG, Kazacos EA. Effect of topical administration of 1 % morphine sulfate solution on signs of pain and corneal wound healing in dogs. Am J Vet Res. 2003;64:813–8.

    Article  PubMed  CAS  Google Scholar 

  66. Reuss-Borst M, Hartmann U, Scheede C, Weiss J. Prevalence of osteoporosis among cancer patients in Germany: prospective data from an oncological rehabilitation clinic. Osteoporos Int. 2011;23:1437–44.

    Article  PubMed  Google Scholar 

  67. Sullivan S, Wagner J, Resnick NM, Nelson J, Perera SK, Greenspan SL. Vertebral fractures and the misclassification of osteoporosis in Men with prostate cancer. J Clin Densitom. 2011;14:348–53.

    Article  PubMed  Google Scholar 

  68. Kalder M, Jager C, Seker-Pektas B, Dinas K, Kyvernitakis I, Hadji P. Breast cancer and bone mineral density: the Marburg breast cancer and osteoporosis trial (MABOT II). Climacteric. 2011;14:352–61.

    Article  PubMed  CAS  Google Scholar 

  69. VanderWalde A, Hurria A. Aging and osteoporosis in breast and prostate cancer. CA Cancer J Clin. 2011;61:139–56.

    Article  PubMed  Google Scholar 

  70. Kilbreath S, Refshauge KM, Beith J, et al. Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: rationale and design of a randomized controlled trial. Contemp Clin Trials. 2011;32:704–9.

    Article  PubMed  CAS  Google Scholar 

  71. The sunshine D-lemma. Sunlight causes skin cancer, but it also produces vitamin D, a substance that seems to prevent some types of cancer and possibly other diseases. Harvard health letter/from Harvard Medical School. 2008;33:6–7.

    Google Scholar 

  72. Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control. 2000;11:459–66.

    Article  PubMed  CAS  Google Scholar 

  73. Weinstein RS. Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med. 2011;365:62–70.

    Article  PubMed  CAS  Google Scholar 

  74. Rackoff PJ, Rosen CJ. Pathogenesis and treatment of glucocorticoid-induced osteoporosis. Drugs Aging. 1998;12:477–84.

    Article  PubMed  CAS  Google Scholar 

  75. Daniell HW. Opioid osteoporosis. Arch Intern Med. 2004;164:338; author reply.

    Article  PubMed  Google Scholar 

  76. Lefkou E, Khamashta M, Hampson G, Hunt BJ. Review: Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity? Lupus. 2010;19:3–12.

    Article  PubMed  CAS  Google Scholar 

  77. Alexandre C, Vico L. Pathophysiology of bone loss in disuse osteoporosis. Joint Bone Spine. 2011;78:572–6.

    Google Scholar 

  78. Sevcik MA, Luger NM, Mach DB, et al. Bone cancer pain: the effects of the bisphosphonate Alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis. Pain. 2004;111:169–80.

    Article  PubMed  CAS  Google Scholar 

  79. Brown SA, Guise TA. Cancer treatment-related bone disease. Crit Rev Eukaryot Gene Expr. 2009;19:47–60.

    Article  PubMed  Google Scholar 

  80. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist. 2004;9:571–91.

    Article  PubMed  CAS  Google Scholar 

  81. Yli-Kyyny T. Bisphosphonates and atypical fractures of femur. J Osteoporos. 2011;2011:754972.

    PubMed  Google Scholar 

  82. Westesson PL. Vertebroplasty–breakthrough in treatment of back pain. Cranio. 2001;19:225.

    PubMed  CAS  Google Scholar 

  83. Al-Nakshabandi NA. Percutaneous vertebroplasty complications. Ann Saudi Med. 2011;31:294–7.

    Article  PubMed  Google Scholar 

  84. Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557–68.

    Article  PubMed  CAS  Google Scholar 

  85. Chew C, Craig L, Edwards R, Moss J, O’Dwyer PJ. Safety and efficacy of percutaneous vertebroplasty in malignancy: a systematic review. Clin Radiol. 2011;66:63–72.

    Article  PubMed  CAS  Google Scholar 

  86. Mercadante S, Fulfaro F, Casuccio A. The use of corticosteroids in home palliative care. Support Care Cancer. 2001;9:386–9.

    Article  PubMed  CAS  Google Scholar 

  87. Twycross R. The risks and benefits of corticosteroids in advanced cancer. Drug Saf. 1994;11:163–78.

    Article  PubMed  CAS  Google Scholar 

  88. Lesniewska B, Nowak KW, Malendowicz LK. Dexamethasone-induced adrenal cortex atrophy and recovery of the gland from partial, steroid-induced atrophy. Exp Clin Endocrinol. 1992;100:133–9.

    Article  PubMed  CAS  Google Scholar 

  89. Malendowicz LK, Nussdorfer GG, Markowska A, Nowak KW. Analysis of the preventive action of ACTH on dexamethasone-induced adrenocortical atrophy in the rat. Cytobios. 1992;71:191–9.

    PubMed  CAS  Google Scholar 

  90. Gonnella P, Alamdari N, Tizio S, Aversa Z, Petkova V, Hasselgren PO. C/EBPbeta regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1. J Cell Biochem. 2011;112:1737–48.

    Article  PubMed  CAS  Google Scholar 

  91. Qin W, Pan J, Wu Y, Bauman WA, Cardozo C. Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1alpha. Biochem Biophys Res Commun. 2010;403:473–8.

    Article  PubMed  CAS  Google Scholar 

  92. Jones A, Hwang DJ, Narayanan R, Miller DD, Dalton JT. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. Endocrinology. 2010;151:3706–19.

    Article  PubMed  CAS  Google Scholar 

  93. Zhao W, Pan J, Zhao Z, Wu Y, Bauman WA, Cardozo CP. Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation. J Steroid Biochem Mol Biol. 2008;110:125–9.

    Article  PubMed  CAS  Google Scholar 

  94. Hueber AJ, Rech J, Kallert S, et al. Paraneoplastic syndrome, infection or arthritis: difficulties in diagnosis. Int J Clin Pract. 2006;60:1310–2.

    Article  PubMed  CAS  Google Scholar 

  95. Morel J, Deschamps V, Toussirot E, et al. Characteristics and survival of 26 patients with paraneoplastic arthritis. Ann Rheum Dis. 2008;67:244–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Research and Education, Hildegard Hospiz, St. Alban Ring 151, Basel, 4020, Switzerland

    Zbigniew (Ben) Zylicz MD, PhD

Authors
  1. Zbigniew (Ben) Zylicz MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zbigniew (Ben) Zylicz MD, PhD .

Editor information

Editors and Affiliations

  1. Analgesics & Pain Research Ltd, Beckenham, United Kingdom

    Magdi Hanna

  2. Hildegard Hospiz, Basel, Switzerland

    Zbigniew (Ben) Zylicz

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Zylicz, Z.(. (2013). Noncancer-Related Pain in Daily Practice. In: Hanna, M., Zylicz, Z. (eds) Cancer Pain. Springer, London. https://doi.org/10.1007/978-0-85729-230-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-230-8_14

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-229-2

  • Online ISBN: 978-0-85729-230-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation